聚焦C期心力衰竭及其合并症的管理—2017 ACC/AHA/HFSA 心力衰竭管理指南更新解读

2017-11-30 中国循环杂志.2017,32(z2):29-32.

2017 年4 月,美国心脏病学会(ACC)、美国心脏协会(AHA)以及美国心力衰竭(心衰)学会(HFSA)联合更新发布了心衰管理指南(以下简称新指南)。该指南对2013 版ACCF/AHA 心衰指南进行了更新,强调在临床实践中应遵循指南指导下的管理和治疗(guideline-directed management and therapy,GDMT),包括指南指导下的临床评估、诊断试验以及药物和非

中文标题:

聚焦C期心力衰竭及其合并症的管理—2017 ACC/AHA/HFSA 心力衰竭管理指南更新解读

发布机构:

发布日期:

2017-11-30

简要介绍:

2017 年4 月,美国心脏病学会(ACC)、美国心脏协会(AHA)以及美国心力衰竭(心衰)学会(HFSA)联合更新发布了心衰管理指南(以下简称新指南)。该指南对2013 版ACCF/AHA 心衰指南进行了更新,强调在临床实践中应遵循指南指导下的管理和治疗(guideline-directed management and therapy,GDMT),包括指南指导下的临床评估、诊断试验以及药物和非药物治疗。新指南更新的内容聚焦于生物标志物、C 期心衰的药物新治疗以及重要合并症的管理。本文对其更新要点做一简要解读。

作者: 南京医科大学第一附属医院心脏科 李小荣 李新立

 

拓展指南:心力衰竭相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=聚焦C期心力衰竭及其合并症的管理—2017 ACC/AHA/HFSA 心力衰竭管理指南更新解读)] GetToolGuiderByIdResponse(projectId=1, id=c71641c0015568c0, title=聚焦C期心力衰竭及其合并症的管理—2017 ACC/AHA/HFSA 心力衰竭管理指南更新解读, enTitle=, guiderFrom=中国循环杂志.2017,32(z2):29-32., authorId=null, author=, summary=2017 年4 月,美国心脏病学会(ACC)、美国心脏协会(AHA)以及美国心力衰竭(心衰)学会(HFSA)联合更新发布了心衰管理指南(以下简称新指南)。该指南对2013 版ACCF/AHA 心衰指南进行了更新,强调在临床实践中应遵循指南指导下的管理和治疗(guideline-directed management and therapy,GDMT),包括指南指导下的临床评估、诊断试验以及药物和非, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Thu Nov 30 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>2017 年4 月,美国心脏病学会(ACC)、美国心脏协会(AHA)以及美国心力衰竭(心衰)学会(HFSA)联合更新发布了心衰管理指南(以下简称新指南)。该指南对2013 版ACCF/AHA 心衰指南进行了更新,强调在临床实践中应遵循指南指导下的管理和治疗(guideline-directed management and therapy,GDMT),包括指南指导下的临床评估、诊断试验以及药物和非药物治疗。新指南更新的内容聚焦于生物标志物、C 期心衰的药物新治疗以及重要合并症的管理。本文对其更新要点做一简要解读。 </P>作者: 南京医科大学第一附属医院心脏科 李小荣 李新立 <P> </P>拓展指南:<strong>与<font color=red>心力衰竭</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=750351c001556ebc" title="慢性心力衰竭患者的心率管理策略" target=_blank>慢性心力衰竭患者的心率管理策略</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=346b51c00152e883" title="中国急性心力衰竭急诊临床实践指南(2017)" target=_blank>中国急性心力衰竭急诊临床实践指南(2017)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=986481c001519690" title="2017 CCS指南:心力衰竭的管理(全面更新)" target=_blank>2017 CCS指南:心力衰竭的管理(全面更新)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=bb75e1c001a949de" title="2017 ACC/AHA/HFSA心力衰竭管理指南更新解读" target=_blank>2017 ACC/AHA/HFSA心力衰竭管理指南更新解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2e3641c001ae3221" title="基层医院心力衰竭临床诊疗中B型利钠肽和N末端B型利钠肽原的应用中国专家建议" target=_blank>基层医院心力衰竭临床诊疗中B型利钠肽和N末端B型利钠肽原的应用中国专家建议</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E5%8A%9B%E8%A1%B0%E7%AB%AD" target=_blank>有关心力衰竭更多指南</a></ul>, tagList=[TagDto(tagId=335, tagName=心力衰竭)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5213, appHits=319, showAppHits=0, pcHits=3653, showPcHits=1734, likes=132, shares=12, comments=12, approvalStatus=1, publishedTime=Sun Feb 18 21:43:14 CST 2018, publishedTimeString=2017-11-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Feb 18 21:43:14 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 17:30:59 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=聚焦C期心力衰竭及其合并症的管理—2017 ACC/AHA/HFSA 心力衰竭管理指南更新解读)])
聚焦C期心力衰竭及其合并症的管理—2017 ACC/AHA/HFSA 心力衰竭管理指南更新解读
下载请点击:
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=289138, encodeId=60d2289138a0, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Feb 19 09:40:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289128, encodeId=5dd9289128b5, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Feb 19 09:22:19 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289109, encodeId=de3628910967, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Feb 19 08:20:16 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289099, encodeId=f3d2289099e8, content=学习了.获益匪浅!感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/17/0ed05bbc4eb124766d2a39104932ec4e.jpg, createdBy=5afd2091871, createdName=情途末路, createdTime=Mon Feb 19 07:39:47 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289076, encodeId=9b9e2890e6e6, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Mon Feb 19 06:09:45 CST 2018, time=2018-02-19, status=1, ipAttribution=)]
    2018-02-19 忠诚向上

    好好学习天天向上

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=289138, encodeId=60d2289138a0, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Feb 19 09:40:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289128, encodeId=5dd9289128b5, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Feb 19 09:22:19 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289109, encodeId=de3628910967, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Feb 19 08:20:16 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289099, encodeId=f3d2289099e8, content=学习了.获益匪浅!感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/17/0ed05bbc4eb124766d2a39104932ec4e.jpg, createdBy=5afd2091871, createdName=情途末路, createdTime=Mon Feb 19 07:39:47 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289076, encodeId=9b9e2890e6e6, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Mon Feb 19 06:09:45 CST 2018, time=2018-02-19, status=1, ipAttribution=)]
    2018-02-19 1dd8c52fm63(暂无匿称)

    了解了解.学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=289138, encodeId=60d2289138a0, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Feb 19 09:40:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289128, encodeId=5dd9289128b5, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Feb 19 09:22:19 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289109, encodeId=de3628910967, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Feb 19 08:20:16 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289099, encodeId=f3d2289099e8, content=学习了.获益匪浅!感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/17/0ed05bbc4eb124766d2a39104932ec4e.jpg, createdBy=5afd2091871, createdName=情途末路, createdTime=Mon Feb 19 07:39:47 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289076, encodeId=9b9e2890e6e6, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Mon Feb 19 06:09:45 CST 2018, time=2018-02-19, status=1, ipAttribution=)]
    2018-02-19 yjs木玉

    好好好好好好好好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=289138, encodeId=60d2289138a0, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Feb 19 09:40:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289128, encodeId=5dd9289128b5, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Feb 19 09:22:19 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289109, encodeId=de3628910967, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Feb 19 08:20:16 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289099, encodeId=f3d2289099e8, content=学习了.获益匪浅!感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/17/0ed05bbc4eb124766d2a39104932ec4e.jpg, createdBy=5afd2091871, createdName=情途末路, createdTime=Mon Feb 19 07:39:47 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289076, encodeId=9b9e2890e6e6, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Mon Feb 19 06:09:45 CST 2018, time=2018-02-19, status=1, ipAttribution=)]
    2018-02-19 情途末路

    学习了.获益匪浅!感谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=289138, encodeId=60d2289138a0, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Feb 19 09:40:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289128, encodeId=5dd9289128b5, content=了解了解.学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Feb 19 09:22:19 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289109, encodeId=de3628910967, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Feb 19 08:20:16 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289099, encodeId=f3d2289099e8, content=学习了.获益匪浅!感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/17/0ed05bbc4eb124766d2a39104932ec4e.jpg, createdBy=5afd2091871, createdName=情途末路, createdTime=Mon Feb 19 07:39:47 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289076, encodeId=9b9e2890e6e6, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Mon Feb 19 06:09:45 CST 2018, time=2018-02-19, status=1, ipAttribution=)]
    2018-02-19 wqkm

    ^_^^_^^_^

    0